Effects of immunoglobulin to prevent coronary allograft vasculopathy in heart transplantation

Author： Suzuki Jun-ichi   Ogawa Masahito   Hirata Yasunobu   Nagai Ryozo   Isobe Mitsuaki  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.16, Iss.8, 2012-08, pp. : 783-789

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bidirectional Ventricular Tachycardia Due to Coronary Allograft Vasculopathy a Unique Presentation

By Bhavnani Sanjeev P.   Clyne Christopher A.  

Annals of Noninvasive Electrocardiology, Vol. 17, Iss. 4, 2012-10 ,pp. : 405-408

Blackwell Publishing

Access to resources Recommend Favorite

Is everolimus useful in preventing allograft rejection and vasculopathy after heart transplant?

By Doggrell Sheila A  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 2, 2004-02 ,pp. : 161-163

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenomics: A Tool to Prevent and Cure Coronary Heart Disease

By  

Current Pharmaceutical Design, Vol. 13, Iss. 36, 2007-12 ,pp. : 3726-3734

Bentham Science Publishers

Access to resources Recommend Favorite

Everolimus suppresses cardiac-allograft vasculopathy

By  

Inpharma, Vol. 1, Iss. 1403, 2003-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Potential Costs and Effects of the National Service Framework for Coronary Heart Disease in the UK

By Vella V.  

PharmacoEconomics, Vol. 21, Iss. 1, 2003-01 ,pp. : 49-60

Adis International

Access to resources Recommend Favorite